This study aimed to evaluate the clinicopathologic significance of CD73 expression in patients with papillary thyroid carcinoma (PTC) and the potential for CD73 to serve as a therapeutic target of PTC. The gene discussed is NT5E; the disease is thyroid gland papillary carcinoma.